JinMatrix ranked among the top searched stocks for 10 days in the past month.


As of 1:30 PM on the 28th, JinMatrix is trading at 18,600 KRW, up 0.81% from the previous day. This marks a 21.97% increase compared to August 12. JinMatrix is known as a specialized company developing diagnostic agents through biotechnology research.

Over the past five days, individual investors have net purchased 10,750 shares, while foreigners and institutions have net purchased 18,460 shares and net sold 3,616 shares, respectively.


On August 24, JinMatrix became a market issue with the headline 'Trump’s AstraZeneca COVID-19 vaccine fast-tracked...'



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing